# Observation Study of the Pharmacokinetics of Adductor Canal Block

> **NCT04916392** · — · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 10 (actual)

## Conditions studied

- Toxicity, Drug

## Interventions

- **DRUG:** Liposomal bupivacaine

## Key facts

- **NCT ID:** NCT04916392
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-03-31
- **Final completion:** 2023-04-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04916392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04916392, "Observation Study of the Pharmacokinetics of Adductor Canal Block". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04916392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*